The CD47/signal-regulatory protein α (SIRPα) complex is key macrophage-related immune check point, which has been increasingly recognized as a promising therapeutic target in DDLPS [23, 24]. This evidence concerns the gene CD47 and dedifferentiated liposarcoma.